Skip to main content
OpenTrials

Clinical trial condition

Epithelial Ovarian Cancer

Explore clinical trials studying Epithelial Ovarian Cancer. Study availability and eligibility vary by location and protocol.

142 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Epithelial Ovarian Cancer trial results

Completed

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study

NCT01617629

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Marin Cancer Care, Inc. Greenbrae, California, United States
  • Scripps Cancer Center La Jolla, California, United States
  • Collaborative Research Group Boca Raton, Florida, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details
Completed

Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer

NCT00408603

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
  • Gynecologic Oncology Associates Newport Beach, California, United States
  • Sharp Clinical Oncology Research San Diego, California, United States
  • Stanford University Stanford, California, United States
View all 20 locations
View Trial Details
Completed

Ovarian Cancer Vaccine for Patients in Remission

NCT01068509

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Marin Cancer Care, Inc. Greenbrae, California, United States
  • Scripps Cancer Center La Jolla, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 18 locations
View Trial Details
Completed

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

NCT01447706

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +27 more
Locations
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Wilshire Oncology Medical Group Corona, California, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

NCT02728492

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Russian Oncological Research Center n.a. N. N. Blokhin RAMS Moscow, Russia
  • State Budgetary Healthcare Institution of Stavropol Territory "Pyatigorsk oncology dispensary" Pyatigorsk, Russia
  • Saint-Peterburg State Budgetary healthcare Institution "City Clinical Oncology Dispensary" Saint Petersburg, Russia
  • BioEq LLC Saint Petersburg, Russia
View Trial Details

Related conditions